Telehealth lifestyle program for veterans with blood cancer
Official title: Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention
Run by VA Pittsburgh Healthcare System · NCT07058571 · Data updated 2026-11-12
This telehealth program will test whether guided aerobic and resistance exercise sessions can improve quality of life, mental health, and pain for veterans living with blood cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | VA Pittsburgh Healthcare System Federal |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | April 3, 2015 |
| Main results expected | January 1, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | July 10, 2025 |
| Trial ID | NCT07058571 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are veterans living with a blood cancer who can safely perform 30–90 minutes of aerobic or resistance exercise at least twice weekly and have a smartphone, tablet, or computer with internet access.
✕Probably not a fit
Patients who cannot meet the exercise requirements, have significant balance or motion disabilities that pose safety risks, lack a smart personal device or internet, or are pregnant are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot will enroll 30 veterans at the VA Pittsburgh Healthcare System to deliver a telehealth-mediated lifestyle intervention centered on progressive resistance and aerobic exercise. Participants complete baseline web surveys on demographics, occupational performance, and telehealth readiness using the VVCMatch tool to identify barriers to remote care. The intervention requires participants to perform 30–90 minutes of exercise at least twice weekly with remote supervision, and outcomes focus on health-related quality of life, mental health, and pain. The trial aims to test feasibility and initial efficacy, with attention to veterans in rural or underserved areas.
Why it matters
Potential benefit: If successful, the program could improve veterans' quality of life, reduce pain and mental health symptoms, and expand access to supportive exercise care through tele-oncology.
How similar studies have gone: Prior telehealth and exercise programs in cancer populations have shown improvements in quality of life and symptom burden, but tailored tele-oncology exercise interventions specifically for veterans with blood cancers remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Living with blood cancer * Physically willing and able to perform 30-90 minutes of exercise a minimum of 2 times per week Exclusion Criteria: * Veterans who are unable to perform 30-90 minutes of exercise twice a week * Veterans with significant disabilities related to balance or motion that would cause a safety risk * Veterans without a smart personal device (smart phone, tablet, or computer) and internet connection (for example, cellular or WIFI connection) * Veterans who are pregnant
Where it's running
-
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Julie Faieta
- Email: Julie.Faieta@va.gov
- Phone: 84128221682
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Targeting measurable residual AML with tagraxofusp plus azacitidine and venetoclax
This trial tests whether adding tagraxofusp to azacitidine and venetoclax can safely help control measurable residual acute myeloid leukemia (AML) in adults who are in remission but still have detectable disease.
-
Evaluating a decision support tool for patients with blood cancers
This study tests a new tool called PRIME to see if it helps older adults with blood cancers make treatment choices that better match their personal preferences compared to regular care.
-
Comprehensive database for studying stem cell transplants and cellular therapies
This study is creating a database to gather information on stem cell transplants and treatments to help improve recovery for patients and donors and make these therapies more accessible to everyone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.